Adalimumab (D2E7) ( DrugBank: Adalimumab )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1
271	強直性脊椎炎	2

96. クローン病

臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00055523 (ClinicalTrials.gov)	April 2002	4/3/2003	A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subject ...	A Phase II Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission i ...	Crohn's Disease	Drug: Adalimumab (D2E7)	Abbott	NULL	Completed	18 Years	75 Years	Both	300	Phase 2	United States

臨床試験数 : 563 / 薬物数 : 372 - (DrugBank : 72) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 145

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00085644 (ClinicalTrials.gov)	January 2004	10/6/2004	Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylo ...	A Phase 3 Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Ada ...	Ankylosing Spondylitis	Biological: adalimumab (D2E7);Biological: placebo	Abbott	NULL	Completed	18 Years	N/A	All	315	Phase 3	United States
2	NCT00195819 (ClinicalTrials.gov)	December 2003	16/9/2005	Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis	A Phase 3, Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Ad ...	Ankylosing Spondylitis	Biological: adalimumab (D2E7);Biological: placebo	Abbott	NULL	Completed	18 Years	N/A	All	82	Phase 3	Canada;United States